NCH Cardiologist Performs First Transcatheter Tricuspid Valve Replacement in Florida
NCH Rooney Heart Institute announces a groundbreaking procedure for patients with valvular heart disease. The operation, performed by a team led by Robert J. Cubeddu, MD, Harvard-trained interventional cardiologist and President of the NCH Rooney Heart Institute, represents the first-ever transcatheter tricuspid valve replacement performed in the State of Florida and one of 10 in the country after recent approval by the U.S. Food and Drug Administration (FDA).
Tricuspid valve disease is highly prevalent and affects thousands of Americans. The condition manifests as a malfunctioning leaky valve that when severe, results in heart failure. Until recently, treatment options have been limited to drugs aimed at providing symptom relief.
The introduction of this minimally invasive transcatheter approach, using the self-expanding valve prosthesis, the “Evoque” valve, is manufactured by Edwards Lifescience, Inc. and is a breakthrough for the thousands affected by this condition.
Naples Comprehensive Health (NCH) remains at the forefront of cardiac care, providing patients with access to the latest advancements. The successful completion of the first transcatheter tricuspid valve replacement in Florida further solidifies NCH’s position as a nationwide leader in cardiovascular care.
For more information about cardiovascular services offered at NCH Rooney Heart Institute, please visit www.nchmd.org.
